These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 5526951)

  • 21. [Portacaval encephalomyelopathy. Case report].
    Lecieux P; Carpentier M; Caridroit M; Carre A; Jaillard J
    Lille Med; 1977 Oct; 22(8):508-11. PubMed ID: 926998
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of chronic hepatic encephalopathy with lactulose (30 cases)].
    Gauthier A; Camatte R; Remacle J; Mathieu C; Torrent M
    Therapeutique; 1970; 46(6):667-70. PubMed ID: 5449836
    [No Abstract]   [Full Text] [Related]  

  • 23. Matched control study of distal splenorenal and portacaval shunts in the treatment of bleeding esophageal varices.
    Busuttil RW; Brin B; Tompkins RK
    Am J Surg; 1979 Jul; 138(1):62-7. PubMed ID: 313718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of chronic portal-systemic encephalopathy with lactulose.
    Bircher J; Müller J; Guggenheim P; Haemmerli UP
    Lancet; 1966 Apr; 1(7443):890-2. PubMed ID: 4159616
    [No Abstract]   [Full Text] [Related]  

  • 25. Cirrhosis, hyperammonemia and Lactulose.
    Rottiers R; Van Egmond J; Verbruggen R; Dierick G; Vermeulen A; Standaert L; De Groote J; Demeulenaere L
    Tijdschr Gastroenterol; 1968; 11(2):123-39. PubMed ID: 5679042
    [No Abstract]   [Full Text] [Related]  

  • 26. [Lactulose in the treatment of chronic portosystemic encephalopathies].
    Seidlová V
    Cesk Gastroenterol Vyz; 1974 Apr; 28(3):201-7. PubMed ID: 4447986
    [No Abstract]   [Full Text] [Related]  

  • 27. [Extension of indications for portal shunt operation through the management of postoperative liver decompensation with peritoneal dialysis].
    Kraemer HJ
    Munch Med Wochenschr; 1968 Feb; 110(7):406-9. PubMed ID: 5695059
    [No Abstract]   [Full Text] [Related]  

  • 28. Hepatic coma in cirrhosis, portal hypertension, and following portacaval shunt. Its etiologies and the current status of its treatment.
    Fischer JE
    Arch Surg; 1974 Mar; 108(3):325-36. PubMed ID: 4149791
    [No Abstract]   [Full Text] [Related]  

  • 29. Conclusions from a controlled trial of the prophylactic portacaval shunt.
    Callow AD; Resnick RH; Chalmers TC; Ishihara AM; Garceau AJ; O'Hara ET
    Surgery; 1970 Jan; 67(1):97-103. PubMed ID: 5308037
    [No Abstract]   [Full Text] [Related]  

  • 30. [Changes in the levels of ammonia and free phenols in patients with portocaval shunt treated with lactulose and/or neomycin compared to a low protein diet (author's transl)].
    Leonhardt H; Sanhueza P
    Med Klin; 1978 Jan; 73(2):63-8. PubMed ID: 622058
    [No Abstract]   [Full Text] [Related]  

  • 31. [Changes of free plasma amino acids in encephalopathy in patients with cirrhosis of the liver after portocaval anastomosis (author's transl)].
    Blahníková L; Horký J; Pechar J; Tomková D; Vosmík J
    Cesk Gastroenterol Vyz; 1975 Oct; 29(7):443-8. PubMed ID: 1192485
    [No Abstract]   [Full Text] [Related]  

  • 32. A controlled study of the therapeutic portacaval shunt.
    Resnick RH; Iber FL; Ishihara AM; Chalmers TC; Zimmerman H
    Gastroenterology; 1974 Nov; 67(5):843-57. PubMed ID: 4547724
    [No Abstract]   [Full Text] [Related]  

  • 33. [Late results of portocaval shunt operation in liver cirrhosis].
    Wildhirt E
    Dtsch Z Verdau Stoffwechselkr; 1970; 30(1):115-7. PubMed ID: 5501412
    [No Abstract]   [Full Text] [Related]  

  • 34. Portal-systemic encephalopathy and portacaval anastomosis: a prospective, controlled investigation.
    Mutchnick MG; Lerner E; Conn HO
    Gastroenterology; 1974 May; 66(5):1005-19. PubMed ID: 4545269
    [No Abstract]   [Full Text] [Related]  

  • 35. Liver function and encephalopathy after partial vs direct side-to-side portacaval shunt: a prospective randomized clinical trial.
    Capussotti L; Vergara V; Polastri R; Bouzari H; Galatola G
    Surgery; 2000 Jun; 127(6):614-21. PubMed ID: 10840355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative study of basal arterial ammonemia and of orally-induced hyperammonemia in chronic portal systemic encephalopathy, treated with neomycin, lactulose, and an association of neomycin and lactulose.
    Pirotte J; Guffens JM; Devos J
    Digestion; 1974; 10(6):435-44. PubMed ID: 4448315
    [No Abstract]   [Full Text] [Related]  

  • 37. Emergency portacaval shunt treatment for bleeding esophageal varices. Prospective study in unselected patients with alcoholic cirrhosis.
    Orloff MJ; Chandler JG; Charters AC; Condon JK; Grambort DE; Modafferi TR; Levin SE
    Arch Surg; 1974 Mar; 108(3):293-9. PubMed ID: 4544309
    [No Abstract]   [Full Text] [Related]  

  • 38. Prospective study of portasystemic encephalopathy after emergency portacaval shunt for bleeding varices.
    Bell RH; Hyde PV; Skivolocki WP; Brimm JE; Orloff MJ
    Am J Surg; 1981 Jul; 142(1):144-50. PubMed ID: 6973288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Postoperative syndromes after portacaval shunt in patients with cirrhosis of the liver (author's transl)].
    Karavias T; Häring R; Weber D
    Leber Magen Darm; 1982 Apr; 12(2):85-9. PubMed ID: 7098748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The mechanism of action of lactulose in portal-systemic encephalopathy. Non-ionic diffusion of ammonia in the canine colon.
    Bircher J; Haemmerli UP; Trabert E; Largiader F; Mocetti T
    Rev Eur Etud Clin Biol; 1971 Apr; 16(4):352-7. PubMed ID: 5564547
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.